Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Fan Zhou | Immunology and Microbiology | Research Excellence Award

Published on by Innovation Technologist

Dr. Fan Zhou | Immunology and Microbiology | Research Excellence Award

Associate Chief Physician | Nanjing Drum Tower Hospital | China

Dr. Fan Zhou is a clinician-scientist specializing in inflammatory bowel disease and gastric cancer, with a strong focus on the immune microenvironment and tumor immune escape mechanisms. His research integrates molecular immunology with translational medicine to identify pathways that drive cancer progression and inflammation-related disease. He has authored multiple peer-reviewed publications in leading international journals across oncology and immunology. As a principal investigator and contributor to nationally and provincially funded projects, his work advances mechanistic understanding and supports the development of personalized therapeutic strategies with clear clinical relevance.

Citation Metrics (Orcid)

10

8

6

4

2

0

Citations
9

Document 1

Citations

Document


View ORCID Profile

Tadesse Tarik Tamir | Medicine | Editorial Board Member

Published on by Innovation Technologist

Mr. Tadesse Tarik Tamir | Medicine | Editorial Board Member

Senior Lecturer at College of Medicine and Health Sciences, University of Gondar | Ethiopia

Mr. Tadesse Tarik Tamir is a dedicated scholar and lecturer in Pediatrics and Child Health Nursing at the University of Gondar, Ethiopia, with a strong research footprint in maternal and child health. He has authored more than 65 peer-reviewed publications, contributing extensively to areas such as neonatal and infant mortality, childhood nutrition, immunization coverage, maternal vaccination, and pediatric mental health. His work is characterized by rigorous analytical approaches, including spatial, multilevel, and hierarchical modeling applied to large demographic and health survey datasets across Africa. Tadesse’s research offers critical insights into public health challenges affecting vulnerable populations, particularly mothers, infants, and young children in low- and middle-income settings. In addition to his academic role, he actively supports knowledge generation through teaching and community engagement, fostering a supportive environment for emerging researchers. Currently advancing his expertise through studies in epidemiology, he demonstrates a strong commitment to evidence-based practice and interdisciplinary collaboration. His contributions continue to inform policy, improve health service delivery, and shape interventions aimed at reducing preventable morbidity and mortality among children and women across sub-Saharan Africa.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Tamir, T. T., Zegeye, A. F., Workneh, B. S., Ali, M. S., Gonete, A. T., Techane, M. A., Wassie, M., Kassie, A. T., Ahmed, M. A., & Tsega, S. S., et al. (2025). Childhood wasting and associated factors in Africa: Evidence from standard demographic and health surveys from 35 countries. BMC Public Health.

Tamir, T. T., Tekeba, B., Techane, M. A., Alemu, T. G., Wubneh, C. A., & Wassie, Y. A. (2025). Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A meta-analysis of demographic and health survey reports between 2015 and 2025. Vaccine.

Kassie, A. T., Zegeye, A. F., Bazezew, A. M., Mamo, E. Y., Gebru, D. M., & Tamir, T. T. (2025). Determinants of pressure to conceive among reproductive age women in sub-Saharan Africa: A multilevel analysis of recent demographic and health surveys in five countries. PLOS Global Public Health.

Mekonen, E. G., Workneh, B. S., Zegeye, A. F., & Tamir, T. T. (2025). Only three out of ten women received adequate postnatal care in sub-Saharan Africa: Evidence from 20 countries demographic and health surveys (2015–2022). BMC Pregnancy and Childbirth.

Tekeba, B., Tamir, T. T., & Zegeye, A. F. (2025). Prevalence and determinants of full vaccination coverage according to the national schedule among children aged 12–35 months in Ghana. Scientific Reports.

Jiawen Wang | Medicine | Best Researcher Award

Published on by Innovation Technologist

Dr. Jiawen Wang | Medicine | Best Researcher Award

Surgeon at Longhua Hospital Shanghai University of Traditional Chinese Medicine | China

Jiawen Wang is a distinguished surgeon and deputy chief physician at a leading hospital specializing in Traditional Chinese Medicine, with a focused expertise in colorectal surgery and integrative medicine. She has made significant contributions to the clinical management of anorectal disorders and inflammatory bowel disease, combining traditional Chinese medicine approaches with minimally invasive surgical and endoscopic interventional techniques. As a principal investigator and key researcher in multiple competitive research projects, she has led studies that bridge traditional practices with modern medical science, investigating clinical outcomes and underlying biological mechanisms. Her scholarly output includes numerous peer-reviewed publications, contributions to books, and active participation as a reviewer for several academic journals. Her work has garnered recognition through multiple awards and patents, reflecting innovation and clinical impact. Collaborating with prominent institutions both nationally and internationally, she has advanced the application of integrative medicine in gastroenterology and pelvic floor medicine. She is also actively involved in professional societies, holding leadership and committee roles that influence clinical standards, research priorities, and training programs in colorectal and integrative medicine. Her contributions are characterized by the integration of traditional methodologies with evidence-based research, promoting high standards in both clinical practice and academic scholarship. She has achieved a total of 116 citations, with 112 citations since 2020, an h-index of 4 overall and since 2020, and an i10-index of 2 both total and since 2020, reflecting the recognition and influence of her work within the scientific and medical community. Her research and clinical practice demonstrate a unique capacity to combine innovation, rigorous scientific validation, and practical applicability, establishing her as a leading figure in the advancement of integrative approaches to colorectal and gastrointestinal medicine.

Profile: Orcid | Google Scholar

Featured Publications

1. Wang, J. W., Pan, Y. B., Cao, Y. Q., Wang, C., Jiang, W. D., Zhai, W. F., & Lu, J. G. (2020). Loganin alleviates LPS‐activated intestinal epithelial inflammation by regulating TLR4/NF‐κB and JAK/STAT3 signaling pathways. The Kaohsiung Journal of Medical Sciences, 36(4), 257–264.

2. Wang, J., Pan, Y., Cao, Y., Zhou, W., & Lu, J. (2019). Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways. Iranian Journal of Basic Medical Sciences, 22(1), 31.

3. Jiang, X., Chen, X., Dong, R., Wang, J., Pan, Y., & Cao, Y. (2023). Establishment of a mouse model of inflammatory bowel disease using dextran sulfate sodium. Advances in Clinical and Experimental Medicine, 32(5), 563–573.

4. Luo, Q., Wang, J., Ge, W., Li, Z., Mao, Y., Wang, C., & Zhang, L. (2024). Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation. Heliyon, 10(7), [Article 7].

5. Liao, W., Luo, Q., Zhang, L., Wang, H., Ge, W., Wang, J., & Zuo, Z. (2024). Genetic overlap between inflammatory bowel disease and iridocyclitis: Insights from a genome-wide association study in a European population. BMC Genomic Data, 25(1), 92.

Kaan Kocali | Health Professions | Best Researcher Award

Published on by Innovation Technologist

Mr. Kaan Kocali | Health Professions | Best Researcher Award

Assistant Professor at Istanbul Gelisim University | Turkey

Dr. Koçali K. is a distinguished academic and occupational health and safety expert with a multidisciplinary background spanning engineering, health sciences, entrepreneurship, and business administration. Currently serving as an Assistant Professor at Istanbul Gelişim University, he is also the Head of the Department of Occupational Health and Safety at the university’s vocational school. His work demonstrates a strong commitment to improving workplace safety practices, risk management, and occupational regulations through extensive academic, project-based, and policy-oriented research.

Publication Profile 

Scopus

Orcid

Google Scholar

Educational Background 

Dr. Koçali holds a Ph.D. in Health and Safety from Istanbul Aydın University, complemented by two master’s degrees—one in Occupational Health and Safety and another in Mining Engineering. He also earned dual bachelor’s degrees in Business Administration and Mining Engineering, further expanding his academic foundation with ongoing undergraduate studies in Entrepreneurship at Istanbul Kultur University. His diverse academic portfolio positions him uniquely at the intersection of technology, management, and safety science.

Professional Experience 

Dr. Koçali is a faculty member at Istanbul Gelişim University, where he teaches and leads initiatives in occupational health and safety education. He also serves as the Head of the Department of Occupational Health and Safety at the university’s vocational school. In his administrative capacity, he chairs the Performance Evaluation Commission and contributes to the Education and Curriculum Board, Ethics Committee, and Internship and Quality Assurance Committees. His leadership extends to European academic exchange as the university’s Erasmus Coordinator.

Research Interests 

Dr. Koçali’s research encompasses a broad spectrum of topics related to occupational health and safety. His key interests include ergonomics and human factors, risk management, workplace inspection, safety in mining and logistics industries, work measurement, and methods engineering. He is also focused on the implementation and evaluation of international safety standards, as well as labor and social security policy analysis.

Awards and Honors 

Dr. Koçali has received numerous accolades recognizing his scholarly contributions. He has been named Best Researcher at the International Research Excellence Awards and earned an Academic Performance Award for ranking top within his department. He was also recognized as the Top Researcher at an International Conference on Cybersecurity. His earlier achievements include the Entrepreneurship Project Award from Istanbul Kultur University, multiple Best Researcher Awards at global conferences, and a prestigious TUBITAK 3001 Fellowship.

Publications 

  • Sosyal Güvenlik Kurumu’nun 2012-2020 Yılları Arası İş Kazaları Göstergelerinin Standardizasyonu
    Cited by: 46 Year: 2021

  • Calculation of Occupational Accident Indicators of Türkiye
    Cited by: 18 Year: 2021

  • Maden Kazalarında Sorumluluklar ve Kusur Oranları
    Cited by: 14 Year: 2021

  • Açık Ocak Maden İşletmelerinde İşçi Anketleri ile İş Sağlığı ve Güvenliği Kültürü ve Uygulamasının Araştırılması
    Cited by: 14 Year: 2018

  • Şırnak Kömür Madeni Kazası Işığında Kömür Madenciliğindeki Uygunsuzluklar Hakkında Öneriler
    Cited by: 10 Year: 2018

Conclusion 

Dr. Koçali K. stands out as an accomplished and forward-thinking academic, with a career that bridges health and safety engineering, strategic risk assessment, and educational leadership. His extensive research and certifications—such as NEBOSH, IOSH, and ISO Lead Auditor credentials—highlight his commitment to fostering safe and sustainable workplace environments. Through impactful publications, award-winning projects, and institutional leadership, he continues to play a vital role in shaping occupational health and safety practices both in Turkey and internationally.

 

 

Muhammad Adnan Qureshi | Public Health | Best Researcher Award

Published on by Innovation Technologist

Assist. Prof. Dr. Muhammad Adnan Qureshi | Public Health | Best Researcher Award

Assistant Professor at Health Services Academy Islamabad Pakistan, Australia

Dr. Muhammad Adnan Qureshi is a multidisciplinary academic and public health consultant with a PhD in the Sociology of Health. He serves as an Assistant Professor at the Health Services Academy in Islamabad, Pakistan. His work spans over a decade of academic, research, and consultancy roles focused on public health, gender, and digital communication. Dr. Qureshi’s research addresses health inequities among marginalized groups, including sexual minorities and youth, using qualitative methodologies and digital tools. His efforts aim to translate sociological theory into actionable public health strategies and inclusive policies.

Publication Profile 

Orcid

Educational Background 🎓

  • PhD in Sociology of Health

    • Specialized in digital sexual health literacy and STI awareness among male youth in Pakistan

    • Thesis Link

  • Additional academic development in:

    • Public health theory and practice

    • Gender and sexuality studies

    • Communication technologies and health behavior

Professional Experience 💼

  • Assistant Professor, Health Services Academy, Islamabad, Pakistan

    • Responsible for teaching, research supervision, and curriculum design in public health and sociology.

  • Public Health Consultant

    • Engaged in national and international consultancy projects focused on inclusive health policy and digital health outreach.

  • Researcher and Author

    • Published scholarly work including peer-reviewed journal articles and a book:

      • “Exposure of Woman through Media: A Sociological Study” (Amazon Link)

  • Experience in:

    • Research project leadership (11 projects)

    • Public health policy advocacy

    • Collaboration with interdisciplinary teams

Research Interests 🔬

  • Gender and Public Health

  • Digital Health Communication

  • Sociology of Sexuality and Marginalization

  • STI Awareness and Youth Health Behavior

  • Inclusive and Culturally Sensitive Health Interventions

  • Technology’s Role in Health Equity and Communication

Awards and Honors🏆✨

  • Nominee for Best Researcher Award (2025)

    • Recognition for impactful research on digital health communication and marginalized communities.

  • Ongoing recognition for innovation in health sociology and advocacy for equity-based interventions.

Conclusion🌟

Dr. Muhammad Adnan Qureshi exemplifies impactful, socially conscious research in the intersection of health, gender, and digital communication. His scholarly contributions challenge stigmas and bridge academic theory with community health practices. By focusing on digital platforms and underrepresented populations, his work enhances access to accurate health information and fosters inclusive public health policies. His commitment to both academic rigor and societal change positions him as a strong candidate for distinguished research awards and further leadership in public health scholarship.

Publications 📚

  1. 🗓️ 2026-12-01
    🎬 Cine Going Dying Culture
    📍 Quaid-i-Azam University Islamabad Archives Bank
    👥 Contributors: Muhammad Adnan Qureshi; Dr. S Anwar Iqbal

  2. 🗓️ 2023-01-01
    🧠 A Qualitative Study Exploring Awareness and Perceptions of Sexually Transmitted Infections (STIs) Amongst a Male University Student Population in Islamabad, Pakistan
    👩‍🏫 Supervisors: Dr. Carolyn Beasley, Dr. Aisling Bailey, Dr. Helen Almond
    🎓 PhD Dissertation (Conceptualization)

  3. 🗓️ 2025-06
    🌱 Two Decades of Renewable Energy ‘Talk’ in Australia
    📰 Sustainable Futures
    🔗 DOI: 10.1016/j.sftr.2025.100684
    👥 Authors: Muhammad Adnan Qureshi, M. Shahabuddin, Dr. Sidra Ishfaq

  4. 🗓️ 2024-11-06
    🧬 Between Silence and Surveillance: Masculinity, Stigma, and the Politics of HIV Awareness Among Male University Students in Pakistan
    📌 14th International Public Health Conference
    🏷️ Theme: Transforming Research into Action: Redefining Public Health through Social and Behavior Change

  5. 🗓️ 2023-11-05
    📢 Unheard and Underserved: Reframing STI Health Literacy Among Pakistani Men in HIV Policy Discourses
    📌 13th International Public Health Conference
    🏷️ Theme: Transforming Research into Action: Redefining Public Health through Social and Behavior Change

  6. 🗓️ 2022-10-01
    🌏 How the COVID-19 Pandemic Impacted My Dream PhD Ethnographic Research: An Autoethnographic Account of Academic Crises Faced by an International Student in Melbourne, Australia
    📌 3rd Swinburne Sarawak Post Research Conference (SSPRC), Malaysia

  7. 🗓️ 2021-12-01
    🧪 How the COVID-19 Pandemic Impacted My Dream PhD Ethnographic Research
    📌 Social Sciences Week, SoSSMFE, Swinburne University of Technology, Melbourne

  8. 🗓️ 2020-11-05
    🚹 How Carelessness and Ignorance in Health-Seeking Behaviors Impact the Sexual and Reproductive Health of Men in Pakistan
    📌 Building Bridges Conference, Swinburne University of Technology, Melbourne

  9. 🗓️ 2019-11-06
    🩺 Why Pakistan is Lagging in Promoting HIV/AIDS Awareness Amongst the Male Population?
    📌 Building Bridges Conference, Swinburne University of Technology, Melbourne

  10. 🗓️ 2020-12-01
    📚 How the COVID-19 Pandemic Impacted My Dream PhD Ethnographic Research: An Autoethnographic Account of Academic Crises Met by an International Student in Melbourne, Australia
    📕 In: Research and Teaching in a Pandemic World
    👤 Author: Muhammad Adnan Qureshi